Join
Live feed
·
PRReleasevia Quantisnow
CytoMed Therapeutics Limited logo

CytoMed makes cash bid for potential acquisition of TC BioPharm Limited's relevant assets

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GDTC (CytoMed Therapeutics Limited) and more on Quantisnow.